Clinical Trials Browser

Phase 1/2 × urelumab × Tumor-Agnostic × Clear all

NCT03792724 2019-01-03

INTRUST

Phase 1/2 Unknown

Neoplasms

NCT00309023 2015-10-12

Study of BMS-663513 in Patients With Advanced Cancer

Phase 1/2 Terminated

Neoplasms